Ziopharm Oncology Inc (ZIOP) Stock Continues to Trend Lower: Down 29% in a Month
When a company makes a key appointment then it usually has an effect on its stock and shows how the market has taken the news. This brings us to the subject of the Ziopharm Oncology Inc (NASDAQ:ZIOP) stock, which tanked by as much as 7% after the company announced the appointment of its new Chief Executive Officer in the form of Kevin S. Boyle Sr yesterday. The appointment went into…